Business Description
![EyePoint Pharmaceuticals Inc EyePoint Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C000008MX.png?14)
EyePoint Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US30233G1004
Description
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 64.74 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.06 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.71 | |||||
Beneish M-Score | -3.67 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.9 | |||||
3-Year EBITDA Growth Rate | 13.8 | |||||
3-Year EPS without NRI Growth Rate | 19.7 | |||||
3-Year FCF Growth Rate | 67.1 | |||||
3-Year Book Growth Rate | 74.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.54 | |||||
9-Day RSI | 28.34 | |||||
14-Day RSI | 29.63 | |||||
6-1 Month Momentum % | -39.44 | |||||
12-1 Month Momentum % | 81.04 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.08 | |||||
Quick Ratio | 5.01 | |||||
Cash Ratio | 4.78 | |||||
Days Inventory | 323.78 | |||||
Days Sales Outstanding | 37.47 | |||||
Days Payable | 665.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.3 | |||||
Shareholder Yield % | 7.93 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 90.5 | |||||
Operating Margin % | -173.6 | |||||
Net Margin % | -157.77 | |||||
FCF Margin % | -33.3 | |||||
ROE % | -55.53 | |||||
ROA % | -33.59 | |||||
ROIC % | -169.56 | |||||
ROC (Joel Greenblatt) % | -787.88 | |||||
ROCE % | -44.1 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 7.56 | |||||
PB Ratio | 1.8 | |||||
Price-to-Tangible-Book | 1.8 | |||||
EV-to-EBIT | -2.47 | |||||
EV-to-EBITDA | -2.49 | |||||
EV-to-Revenue | 3.87 | |||||
EV-to-Forward-Revenue | 4.31 | |||||
EV-to-FCF | -11.64 | |||||
Price-to-Median-PS-Value | 0.88 | |||||
Price-to-Net-Current-Asset-Value | 1.88 | |||||
Price-to-Net-Cash | 2.04 | |||||
Earnings Yield (Greenblatt) % | -40.49 | |||||
FCF Yield % | -3.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EYPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EyePoint Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 50.019 | ||
EPS (TTM) ($) | -1.81 | ||
Beta | 2.27 | ||
Volatility % | 287.93 | ||
14-Day RSI | 29.63 | ||
14-Day ATR ($) | 0.747686 | ||
20-Day SMA ($) | 10.14 | ||
12-1 Month Momentum % | 81.04 | ||
52-Week Range ($) | 5.67 - 30.99 | ||
Shares Outstanding (Mil) | 52.08 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
EyePoint Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
EyePoint Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
EyePoint Pharmaceuticals Inc Frequently Asked Questions
What is EyePoint Pharmaceuticals Inc(EYPT)'s stock price today?
The current price of EYPT is $9.01. The 52 week high of EYPT is $30.99 and 52 week low is $5.67.
When is next earnings date of EyePoint Pharmaceuticals Inc(EYPT)?
The next earnings date of EyePoint Pharmaceuticals Inc(EYPT) is 2024-08-02 Est..
Does EyePoint Pharmaceuticals Inc(EYPT) pay dividends? If so, how much?
EyePoint Pharmaceuticals Inc(EYPT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |